MetaCap

DaVita (DVA) vs NewGenIvf Group (NIVF)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

DaVita is the larger company by market cap ($10.13 billion vs $80,770), about 125402.8 times the size. On valuation, NewGenIvf Group trades at a lower forward P/E (0.0x vs 9.5x for DaVita). NewGenIvf Group converts more of its revenue into profit, with a net margin of 209.0% versus 5.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DVA-8.91%NIVF-74.62%
+1345%+601%-142%
Oct 7, 20261 yearNov 20, 2026
DVA-10.16%NIVF-62.69%
+2024%+931%-162%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DVA versus NIVF key metrics
MetricDVANIVF
Share price$161.03$0.0269
Market cap$10.13B$80.77K
1-day change+3.00%-23.14%
YTD return+41.74%—
1-year return+33.91%—
5-year return+65.52%—
P/E ratio (TTM)12.19—
Forward P/E9.520.00
EPS (TTM)$13.21$-34,064.71
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$13.64B$4.73M
Revenue growth (YoY)+6.46%-13.01%
Net income (latest FY)$746.80M$9.88M
Gross margin—20.22%
Operating margin14.98%-226.95%
Net margin5.47%209.02%
52-week high$247.49$7,257.60
52-week low$101.00$0.0229
Distance from 52-week high-34.93%-100.00%
Analyst consensusbuynone
Avg. price target upside+38.04%+472316.36%
Average volume738.70K6.57M
Shares outstanding62.90M2.99M
Employees78,00087
SectorHealth CareHealth Care
IndustryMisc Health and Biotechnology ServicesMisc Health and Biotechnology Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • DaVita is about 125402.8 times larger than NewGenIvf Group by market value ($10.13B vs $80.77K).
  • NewGenIvf Group is more profitable, keeping 209.0 cents of every revenue dollar as net income versus 5.5 cents for DaVita.
  • DaVita grew revenue faster in its latest fiscal year (+6.46% vs -13.01%).

About DaVita

DVA stock →

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

Health Care · Misc Health and Biotechnology Services · 78,000 employees

About NewGenIvf Group

NIVF stock →

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing.

Health Care · Misc Health and Biotechnology Services · 87 employees

DVA vs NIVF FAQ

Which is bigger, DaVita or NewGenIvf Group?

DaVita (DVA) is larger, with a market capitalization of $10.13B compared with $80.77K for NewGenIvf Group (NIVF).

Are DaVita and NewGenIvf Group in the same industry?

Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.

More comparisons